Cargando…

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a current pandemic (COVID-19) with devastating consequences in public health and economic stability. Using a peptide array to map the antibody response of plasma from healing patients (12) and heathy patients (6), we...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrera-Soler, Lluc, Daguer, Jean-Pierre, Barluenga, Sofia, Vadas, Oscar, Cohen, Patrick, Pagano, Sabrina, Yerly, Sabine, Kaiser, Laurent, Vuilleumier, Nicolas, Winssinger, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480855/
https://www.ncbi.nlm.nih.gov/pubmed/32903266
http://dx.doi.org/10.1371/journal.pone.0238089
Descripción
Sumario:A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a current pandemic (COVID-19) with devastating consequences in public health and economic stability. Using a peptide array to map the antibody response of plasma from healing patients (12) and heathy patients (6), we identified three immunodominant linear epitopes, two of which correspond to key proteolytic sites on the spike protein (S1/S2 and S2’) known to be critical for cellular entry. We show biochemical evidence that plasma positive for the epitope adjacent to the S1/S2 cleavage site inhibits furin-mediated proteolysis of spike.